Filing Details
- Accession Number:
- 0001179110-15-007021
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-05-04 16:58:10
- Reporting Period:
- 2015-05-01
- Filing Date:
- 2015-05-04
- Accepted Time:
- 2015-05-04 16:58:10
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1436304 | Kythera Biopharmaceuticals Inc | KYTH | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1416180 | R Keith Leonard | 30930 Russell Ranch Road 3Rd Floor Westlake Village CA 91362 | President & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2015-05-01 | 600 | $46.41 | 862,473 | No | 4 | S | Indirect | See footnote |
Common Stock | Disposition | 2015-05-01 | 8,532 | $45.35 | 853,941 | No | 4 | S | Indirect | See footnote |
Common Stock | Disposition | 2015-05-01 | 1,100 | $44.26 | 852,841 | No | 4 | S | Indirect | See footnote |
Common Stock | Disposition | 2015-05-01 | 2,768 | $43.56 | 850,073 | No | 4 | S | Indirect | See footnote |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | See footnote |
No | 4 | S | Indirect | See footnote |
No | 4 | S | Indirect | See footnote |
No | 4 | S | Indirect | See footnote |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 47,103 | Indirect | See footnote |
Common Stock | 47,103 | Indirect | See footnote |
Common Stock | 189 | Indirect | See footnote |
Common Stock | 189 | Indirect | See footnote |
Common Stock | 9,105 | Direct |
Footnotes
- The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan which expires April 30, 2015.
- Shares held by Leonard Family Trust, dated August 28, 1996, Keith Richard Leonard, Jr. and Nanette LaRosa Leonard, Trustees.
- Shares held by Keith Richard Leonard, Jr., Retained Annuity Trust, Dated 12 April, 2010, Keith Richard Leonard, Jr., Trustee.
- Shares held by Nanette LaRosa Leonard, Retained Annuity Trust, Dated 12 April, 2010, Keith Richard Leonard, Jr., Trustee.
- Shares held by Keith R. Leonard III. Keith R. Leonard III is the son of the Reporting Person.
- Shares held by Nina R. Leonard. Nina R. Leonard is the daughter of the Reporting Person.
- The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $46.08 to $46.96, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $45.00 to $45.94, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $44.02 to $44.84, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $43.16 to $43.98, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.